Austin, Texas, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Digital Breast Tomosynthesis Market Size & Growth Analysis:
According to SNS Insider, The Digital Breast Tomosynthesis Market size was valued at USD 3.02 billion in 2024 and is projected to reach USD 8.39 billion by 2032, growing at a CAGR of 13.64% over the forecast period of 2025–2032. The increasing adoption of three-dimensional breast imaging systems across hospitals, diagnostic imaging centers, and specialty clinics is significantly contributing to market expansion.
Technological advancements in detector sensitivity, image reconstruction algorithms, and artificial intelligence integration are further strengthening digital breast tomosynthesis market growth. Additionally, rising awareness of breast cancer screening, supportive reimbursement policies in select regions, and the growing geriatric female population are fueling sustained demand for digital breast tomosynthesis systems worldwide.
Get a Sample Report of Digital Breast Tomosynthesis Market: https://www.snsinsider.com/sample-request/8036
U.S. Digital Breast Tomosynthesis Market Insights:
The U.S. digital breast tomosynthesis market size was valued at USD 1.36 billion in 2024 and is projected to reach USD 3.74 billion by 2032, expanding at a CAGR of 13.42% during the forecast period of 2025–2032. Strong adoption of advanced breast imaging technologies, widespread availability of screening programs, and favorable reimbursement frameworks are key factors driving market growth in the United States. The country continues to lead in the deployment of digital breast tomosynthesis systems due to high healthcare expenditure, early technology adoption, and increasing emphasis on improving diagnostic accuracy and reducing false-positive recall rates in breast cancer screening.
Major Players Analysis Listed in the Digital Breast Tomosynthesis Market Report are
- Hologic
- GE Healthcare
- Siemens Healthineers
- FUJIFILM Corporation
- Canon Medical Systems
- Philips Healthcare
- Planmed Oy
- Carestream Health
- IMS Giotto S.p.A.
- Analogic Corporation
- PerkinElmer
- Trivitron Healthcare
- Internazionale Medico Scientifica
- DMS Imaging
- Adaptix Ltd.
- Guangzhou Ysenmed Co., Ltd.
- Sino Medical Device Technology Co., Ltd.
- Volpara Health Technologies Ltd.
- Samsung Medison
- Neusoft Medical Systems
Digital Breast Tomosynthesis Market Report Scope
| Report Attributes | Details |
| Market Size in 2024 | USD 3.02 Billion |
| Market Size by 2032 | USD 8.39 Billion |
| CAGR | CAGR of 13.64% From 2025 to 2032 |
| Base Year | 2024 |
| Forecast Period | 2025-2032 |
| Historical Data | 2021-2023 |
| Regional Analysis/Coverage | North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America). |
Segmentation Analysis:
By Product Type
In 2024, 2D/3D combination tomosynthesis systems led the digital breast tomosynthesis market analysis as they accounted for a major revenue share of 46.2%. Their versatility makes them the perfect solution for traditional mammography rooms, enjoying the conversion to digital. The software solutions segment is the fastest growing, as more advanced diagnostic tools incorporating AI, automatic recording of findings, and cloud-based archiving find escalating demand.
By Technology
3D mammography led the global digital breast tomosynthesis market with an overall share of 58.4% in 2024 due to its ability to produce more detailed (layered) images relative to conventional digital mammography. Contrast-enhanced mammography is the fastest-growing technology as it can capture angiogenesis in tumors and provide better lesion contrast.
By Application
In 2024, breast cancer screening was the major application and accounted for a 61.5% share of the overall digital breast tomosynthesis market. This leadership position is owed to national-level screening programs, the rise of awareness, and early detection requirements imposed by governments and healthcare institutions. Dense breast imaging was the most rapidly growing application. Increased awareness and improved reimbursement structures are increasing the use of digital breast tomosynthesis for the evaluation of dense breasts.
By End-User
The hospitals accounted for the largest digital breast tomosynthesis market share of value of 49.7% in 2024. Their high patient loads, comprehensive diagnostic systems, and greater resources for implementing new imaging tools, such as DBT, have contributed to their growing dominance. Diagnostic imaging centers segment is relatively the fastest end-user category due to its ability to provide specific, cost-effective imaging services with a faster delivery period.
Need Any Customization Research on Digital Breast Tomosynthesis Market, Enquire Now: https://www.snsinsider.com/enquiry/8036
Key Digital Breast Tomosynthesis Market Segments
By Product Type
- Standalone 3D Tomosynthesis Systems
- 2D/3D Combination Tomosynthesis Systems
- Software Solutions
- Full-Field Digital Mammography (FFDM) Systems
By Technology
- 3D Mammography
- Digital Mammography
- Contrast-Enhanced Mammography
By Application
- Breast Cancer Screening
- Breast Cancer Diagnosis
- Dense Breast Imaging
By End User
- Hospitals
- Diagnostic Imaging Centers
- Research Institutions
- Others (Ambulatory Surgical Centers (ASCs), Specialty Clinics, and Mobile Imaging Units)
Regional Insights:
Based on region, the digital breast tomosynthesis market was dominated by North America in 2024, and this is primarily attributed to the presence of developed healthcare infrastructure, high screening compliance, and strong reimbursement policies.
Asia Pacific is the most lucrative region for the global digital breast tomosynthesis market, and it is expected to grow at the highest CAGR owing to rapid urbanization, increasing funding for healthcare facilities, and growing breast cancer awareness.
Recent Developments:
- In May 2024, Siemens Healthineers introduced the Mammomat B.brilliant DBT system, featuring AI-powered reconstruction and personalized compression technology. This system enhances image quality while reducing radiation dose and aims to improve patient comfort and diagnostic accuracy in breast screening.
- In February 2024, Hologic received FDA clearance for its Genius AI Detection technology for DBT, enabling automated identification of suspicious breast lesions. The tool is designed to support radiologists by streamlining workflows and reducing interpretation time during 3D mammography exams.
For a Personalized Briefing with Our Industry Analysts, Connect Now: https://www.snsinsider.com/request-analyst/8036
Exclusive Sections of the Report (The USPs):
- REIMBURSEMENT & PAYER COVERAGE METRICS – helps you understand market accessibility by analyzing country-wise reimbursement coverage, payer policies, and cost-effectiveness and HTA outcomes influencing DBT adoption across healthcare systems.
- R&D INVESTMENT & FUNDING MOMENTUM INDICATORS – helps you assess innovation strength through venture capital flows, IPO activity, and public–private or regulator-backed funding initiatives supporting DBT development and commercialization.
- TECHNOLOGY INTEGRATION & DIGITAL TRANSFORMATION TRENDS – helps you identify adoption of advanced capabilities by tracking AI-driven image analysis, predictive analytics, and cloud-based imaging and data integration platforms.
- CLINICAL PIPELINE & TRIAL PROGRESSION INSIGHTS – helps you evaluate clinical validation by analyzing DBT trial activity by modality and region, enrollment trends, and diagnostic access challenges impacting trial execution.
- SCREENING UPTAKE & EQUIPMENT PENETRATION BENCHMARKS – helps you measure real-world adoption by tracking national screening program inclusion rates and global penetration of DBT equipment across healthcare facilities.
Access Complete Report Details of Digital Breast Tomosynthesis Market Analysis & Outlook: https://www.snsinsider.com/reports/digital-breast-tomosynthesis-market-8036
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
